Influence of Amlodipine Enantiomers on Human Microsomal Cytochromes P450: Stereoselective Time-Dependent Inhibition of CYP3A Enzyme Activity.

about

Influence of Amlodipine Enantiomers on Human Microsomal Cytochromes P450: Stereoselective Time-Dependent Inhibition of CYP3A Enzyme Activity.

Item

http://www.wikidata.org/entity/Q48049878

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Influence of Amlodipine Enanti ...... tion of CYP3A Enzyme Activity.

@en

Influence of Amlodipine Enanti ...... tion of CYP3A Enzyme Activity.

@nl

type

Item

label

Influence of Amlodipine Enanti ...... tion of CYP3A Enzyme Activity.

@en

Influence of Amlodipine Enanti ...... tion of CYP3A Enzyme Activity.

@nl

prefLabel

Influence of Amlodipine Enanti ...... tion of CYP3A Enzyme Activity.

@en

Influence of Amlodipine Enanti ...... tion of CYP3A Enzyme Activity.

@nl

P1476

Influence of Amlodipine Enanti ...... ition of CYP3A Enzyme Activity

@en

P2093

Pavel Anzenbacher

http://www.w3.org/2001/XMLSchema#string

P2860

Dual effects of ketoconazole cis-enantiomers on CYP3A4 in human hepatocytes and HepG2 Cells

Quantum mechanically derived AMBER-compatible heme parameters for various states of the cytochrome P450 catalytic cycle.

Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.

Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment.

Metabolism and kinetics of amlodipine in man.

Cytochromes P450 and metabolism of xenobiotics.

Amlodipine metabolism in human liver microsomes and roles of CYP3A4/5 in the dihydropyridine dehydrogenation.

Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.

Structural basis for ligand promiscuity in cytochrome P450 3A4.

Pharmacogenetics - five decades of therapeutic lessons from genetic diversity.

P31

scholarly article

P356

10.3390/MOLECULES22111879

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ondrej Holas

Kristýna Krasulová

P577

2017-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29099769

http://www.w3.org/2001/XMLSchema#string

P921

stereoselectivity

P932

6150391

http://www.w3.org/2001/XMLSchema#string